Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Durvalumab Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Durvalumab Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Elacestrant Ductal Breast Carcinoma In Situ	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Encequidar Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Encequidar Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Encequidar Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Fianlimab Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Fianlimab Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Fianlimab Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Gsk 5733584 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Gsk 5733584 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Gsk 5733584 Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Inno-206 Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Inno-206 Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Irinotecan Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Irinotecan Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Ivonescimab Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Ladiratuzumab Vedotin Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Ladiratuzumab Vedotin Hormone Receptor Negative Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Ladiratuzumab Vedotin Hormone Receptor Positive Tumor	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Lasofoxifene Angiosarcoma	QuantumLeap Healthcare Collaborative	P2	CCC (53)

Showing 26 to 50 of 278 assets

PreviousPage 2 of 12Next